SecBot SecBot

SLAIY

SOLAI Ltd
OTC· CIK 0001517496
$0.3000 +0.00 (+0.00%)
Oct 26 4:00 PM ET · prev $0.3000
1 year
−98.2%
from $16.73 · Oct 28
30 days
+6.2%
from $0.2825
52-week range
$0.1150–607.60
−100% from high · low Sep 17
Avg volume 20D
986
Oct 2 spike 3.3K
Short interest
23.5K
−0.7%
Days to cover
9.7
at average volume
Filing reports
2
analyzed by SecBot
SecBot read MIXED 2 reports · 90 days
Balance 0 bearish · 0 bullish · 2 neutral oldest → newest, height = score
Avg score ·High conf. 2/2
Strongest NEUTRAL SOLAI Limited reported the resignations of independent director Zhan Chen (effective August 21, 2026) and…
All reports →

Price

Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.

Signal stack

Where each data set points today.

  • Short sellersSTEADY

    Short interest −0.7% to 23.5K shares. 9.7 days to cover.

  • TrendDOWNTREND

    22% below its 50-day average.

Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 18, 2026 SEC
SOLAI Limited reported the resignations of independent director Zhan Chen (effective August 21, 2026) and CFO Qiang…
6-K — Impact 3/10
Aug 25, 2026 Clinical trial readout
Results Pending: Vaginal Photobiomodulation for Chronic Pelvic Pain (Phase 2) — Completed 69d ago
Trial: Vaginal Photobiomodulation for Chronic Pelvic Pain Sponsor: SoLa Pelvic Therapy Phase: Phase
Aug 17, 2026 SEC
SOLAI Limited reported that shareholders at its EGM on August 14, 2026, approved a massive increase in authorised…
6-K — Impact 3/10

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current Q———$0.00
Next Q———$0.00
Current FY———$0.00
Next FY———$0.00

Short side

FINRA· Oct 15, 2026
23,473
shares short
-0.7%
vs prior settlement
9.7
days to cover
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Aug 25, 2026
Trial readout
Results Pending: Vaginal Photobiomodulation for Chronic Pelvic Pain (Phase 2) — Completed 69d ago
Trial: Vaginal Photobiomodulation for Chronic Pelvic Pain Sponsor: SoLa Pelvic Therapy Phase: Phase 2 | Completed: 2026-06-17 Conditions: Chronic…

SecBot reports

2 filings · 0 bullish · 0 bearish · 2 neutral
All SLAIY filing & press-release reports (2)